Correlation Between Pfizer and ProShares UltraPro

Can any of the company-specific risk be diversified away by investing in both Pfizer and ProShares UltraPro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ProShares UltraPro into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and ProShares UltraPro Short, you can compare the effects of market volatilities on Pfizer and ProShares UltraPro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ProShares UltraPro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ProShares UltraPro.

Diversification Opportunities for Pfizer and ProShares UltraPro

-0.85

Correlation Coefficient

Pfizer  ProShares UltraPro

Pay attention - limited upside

The 3 months correlation between Pfizer and ProShares is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ProShares UltraPro Short in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProShares UltraPro Short and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ProShares UltraPro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProShares UltraPro Short has no effect on the direction of Pfizer i.e., Pfizer and ProShares UltraPro go up and down completely randomly.

Pair Corralation between Pfizer and ProShares UltraPro

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.62 times more return on investment than ProShares UltraPro. However, Pfizer Inc is 1.61 times less risky than ProShares UltraPro. It trades about 0.13 of its potential returns per unit of risk. ProShares UltraPro Short is currently generating about -0.27 per unit of risk. If you would invest  2,163  in Pfizer Inc on April 20, 2025 and sell it today you would earn a total of  284.00  from holding Pfizer Inc or generate 13.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	98.41%
Values	Daily Returns

Pfizer Inc  vs.  ProShares UltraPro Short

Pfizer Inc

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal technical and fundamental indicators, Pfizer exhibited solid returns over the last few months and may actually be approaching a breakup point.

ProShares UltraPro Short

Risk-Adjusted Performance

Very Weak

Over the last 90 days ProShares UltraPro Short has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Etf's basic indicators remain fairly stable which may send shares a bit higher in August 2025. The latest fuss may also be a sign of long-term up-swing for the fund sophisticated investors.

Pair Trading with Pfizer and ProShares UltraPro

The main advantage of trading using opposite Pfizer and ProShares UltraPro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ProShares UltraPro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProShares UltraPro will offset losses from the drop in ProShares UltraPro's long position.

The idea behind Pfizer Inc and ProShares UltraPro Short pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.